Dr Reddys Laboratories (RDY) EBT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 21.00% |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | -29.91% |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn | -36.69% |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 33.76% |
| 5 | Bausch Health Companies | 2.33 Bn | 496.37 Mn | 2.10 Bn | 63.93% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 91.91% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 5.52% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 33.42% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.69% |
| Mar 31, 2026 | -53.88% |
| Dec 31, 2025 | 2.27% |
| Sep 30, 2025 | 1.87% |
| Jun 30, 2025 | 5.40% |
| Mar 31, 2025 | 91.41% |
| Dec 31, 2024 | 39.94% |
| Sep 30, 2024 | 21.37% |
| Jun 30, 2024 | 9.68% |
| Mar 31, 2024 | 24.47% |
| Dec 31, 2023 | 25.85% |
| Sep 30, 2023 | 81.05% |
| Jun 30, 2023 | 24.92% |
| Mar 31, 2023 | 22.76% |
| Dec 31, 2022 | 19.47% |
| Sep 30, 2022 | 69.19% |
| Jun 30, 2022 | 21.11% |
| Mar 31, 2022 | -26.43% |
| Dec 31, 2021 | -1.59% |
| Sep 30, 2021 | 15.07% |